Reuters logo
BRIEF-Intercept Pharma posts positive results from Phase 2 AESOP trial
2017年10月23日 / 晚上8点24分 / 25 天前

BRIEF-Intercept Pharma posts positive results from Phase 2 AESOP trial

Oct 23 (Reuters) - Intercept Pharmaceuticals Inc

* Intercept announces positive results from Phase 2 AESOP trial evaluating OCA for the treatment of patients with primary sclerosing cholangitis at The Liver Meeting 2017

* Intercept Pharmaceuticals Inc - ‍OCA met primary endpoint of alkaline phosphatase (ALP) reduction at 24 weeks​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below